446 related articles for article (PubMed ID: 11408215)
21. Pseudomonas aeruginosa reveals high intrinsic resistance to penem antibiotics: penem resistance mechanisms and their interplay.
Okamoto K; Gotoh N; Nishino T
Antimicrob Agents Chemother; 2001 Jul; 45(7):1964-71. PubMed ID: 11408209
[TBL] [Abstract][Full Text] [Related]
22. An efflux pump (MexAB-OprM) of Pseudomonas aeruginosa is associated with antibacterial activity of Epigallocatechin-3-gallate (EGCG).
Kanagaratnam R; Sheikh R; Alharbi F; Kwon DH
Phytomedicine; 2017 Dec; 36():194-200. PubMed ID: 29157815
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of a structural model of Pseudomonas aeruginosa outer membrane protein OprM, an efflux component involved in intrinsic antibiotic resistance.
Wong KK; Brinkman FS; Benz RS; Hancock RE
J Bacteriol; 2001 Jan; 183(1):367-74. PubMed ID: 11114937
[TBL] [Abstract][Full Text] [Related]
24. Conessine as a novel inhibitor of multidrug efflux pump systems in Pseudomonas aeruginosa.
Siriyong T; Srimanote P; Chusri S; Yingyongnarongkul BE; Suaisom C; Tipmanee V; Voravuthikunchai SP
BMC Complement Altern Med; 2017 Aug; 17(1):405. PubMed ID: 28806947
[TBL] [Abstract][Full Text] [Related]
25. Adaptive resistance to cationic compounds in Pseudomonas aeruginosa.
Skiada A; Markogiannakis A; Plachouras D; Daikos GL
Int J Antimicrob Agents; 2011 Mar; 37(3):187-93. PubMed ID: 21295448
[TBL] [Abstract][Full Text] [Related]
26. Efflux unbalance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
Vettoretti L; Plésiat P; Muller C; El Garch F; Phan G; Attrée I; Ducruix A; Llanes C
Antimicrob Agents Chemother; 2009 May; 53(5):1987-97. PubMed ID: 19258280
[TBL] [Abstract][Full Text] [Related]
27. Detection of drug-resistance mechanism of Pseudomonas aeruginosa developing from a sensitive strain to a persister during carbapenem treatment.
Shen JL; Fang YP
Genet Mol Res; 2015 Jun; 14(2):6723-32. PubMed ID: 26125881
[TBL] [Abstract][Full Text] [Related]
28. The Efflux Pump MexXY/OprM Contributes to the Tolerance and Acquired Resistance of Pseudomonas aeruginosa to Colistin.
Puja H; Bolard A; Noguès A; Plésiat P; Jeannot K
Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31964794
[TBL] [Abstract][Full Text] [Related]
29. [Drug screening model acting on out-membrane protein OprM in pseudomonas aeruginosa efflux pump system].
Tian R; Yu LY; Xiao CL; Zuo L; Yao TJ; Yang LX
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Aug; 26(4):359-63. PubMed ID: 15379256
[TBL] [Abstract][Full Text] [Related]
30. The role of mex-gene products in antibiotic extrusion in Pseudomonas aeruginosa.
Yoneyama H; Ocaktan A; Tsuda M; Nakae T
Biochem Biophys Res Commun; 1997 Apr; 233(3):611-8. PubMed ID: 9168899
[TBL] [Abstract][Full Text] [Related]
31. Extrusion of penem antibiotics by multicomponent efflux systems MexAB-OprM, MexCD-OprJ, and MexXY-OprM of Pseudomonas aeruginosa.
Okamoto K; Gotoh N; Nishino T
Antimicrob Agents Chemother; 2002 Aug; 46(8):2696-9. PubMed ID: 12121960
[TBL] [Abstract][Full Text] [Related]
32. In-vivo impact of the MexXY efflux system on aminoglycoside efficacy in an experimental model of Pseudomonas aeruginosa pneumonia treated with tobramycin.
Martha B; Croisier D; Durand D; Hocquet D; Plesiat P; Piroth L; Portier H; Chavanet P
Clin Microbiol Infect; 2006 May; 12(5):426-32. PubMed ID: 16643518
[TBL] [Abstract][Full Text] [Related]
33. Cumulative effects of several nonenzymatic mechanisms on the resistance of Pseudomonas aeruginosa to aminoglycosides.
El'Garch F; Jeannot K; Hocquet D; Llanes-Barakat C; Plésiat P
Antimicrob Agents Chemother; 2007 Mar; 51(3):1016-21. PubMed ID: 17194835
[TBL] [Abstract][Full Text] [Related]
34. Contribution of mexAB-oprM and mexXY (-oprA) efflux operons in antibiotic resistance of clinical Pseudomonas aeruginosa isolates in Tabriz, Iran.
Goli HR; Nahaei MR; Rezaee MA; Hasani A; Samadi Kafil H; Aghazadeh M; Sheikhalizadeh V
Infect Genet Evol; 2016 Nov; 45():75-82. PubMed ID: 27562333
[TBL] [Abstract][Full Text] [Related]
35. Measurement of Pseudomonas aeruginosa multidrug efflux pumps by quantitative real-time polymerase chain reaction.
Yoneda K; Chikumi H; Murata T; Gotoh N; Yamamoto H; Fujiwara H; Nishino T; Shimizu E
FEMS Microbiol Lett; 2005 Feb; 243(1):125-31. PubMed ID: 15668010
[TBL] [Abstract][Full Text] [Related]
36. Multiple genotypic changes in hypersusceptible strains of Pseudomonas aeruginosa isolated from cystic fibrosis patients do not always correlate with the phenotype.
Wolter DJ; Black JA; Lister PD; Hanson ND
J Antimicrob Chemother; 2009 Aug; 64(2):294-300. PubMed ID: 19468029
[TBL] [Abstract][Full Text] [Related]
37. Contributions of MexAB-OprM and an EmrE homolog to intrinsic resistance of Pseudomonas aeruginosa to aminoglycosides and dyes.
Li XZ; Poole K; Nikaido H
Antimicrob Agents Chemother; 2003 Jan; 47(1):27-33. PubMed ID: 12499164
[TBL] [Abstract][Full Text] [Related]
38. Mutations in Gene
Bolard A; Plésiat P; Jeannot K
Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29133559
[TBL] [Abstract][Full Text] [Related]
39. Substrate specificities of MexAB-OprM, MexCD-OprJ, and MexXY-oprM efflux pumps in Pseudomonas aeruginosa.
Masuda N; Sakagawa E; Ohya S; Gotoh N; Tsujimoto H; Nishino T
Antimicrob Agents Chemother; 2000 Dec; 44(12):3322-7. PubMed ID: 11083635
[TBL] [Abstract][Full Text] [Related]
40. Aminoglycoside efflux in Pseudomonas aeruginosa: involvement of novel outer membrane proteins.
Jo JT; Brinkman FS; Hancock RE
Antimicrob Agents Chemother; 2003 Mar; 47(3):1101-11. PubMed ID: 12604548
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
